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Abstract
Years of endemic infections with highly pathogenic avian influenza (HPAI) A subtype H5N1 virus in poultry and high
numbers of infections in humans provide ample opportunity in Egypt for H5N1-HPAIV to develop pandemic potential. In an
effort to better understand the viral determinants that facilitate human infections of the Egyptian H5N1-HPAIVvirus, we
developed a new phylogenetic algorithm based on a new distance measure derived from the informational spectrum
method (ISM). This new approach, which describes functional aspects of the evolution of the hemagglutinin subunit 1
(HA1), revealed a growing group G2 of H5N1-HPAIV in Egypt after 2009 that acquired new informational spectrum (IS)
properties suggestive of an increased human tropism and pandemic potential. While in 2006 all viruses in Egypt belonged
to the G1 group, by 2011 these viruses were virtually replaced by G2 viruses. All of the G2 viruses displayed four
characteristic mutations (D43N, S120(D,N), (S,L)129D and I151T), three of which were previously reported to increase
binding to the human receptor. Already in 2006–2008 G2 viruses were significantly (p,0.02) more often found in humans
than expected from their overall prevalence and this further increased in 2009–2011 (p,0.007). Our approach also identified
viruses that acquired additional mutations that we predict to further enhance their human tropism. The extensive evolution
of Egyptian H5N1-HPAIV towards a preferential human tropism underlines an urgent need to closely monitor these viruses
with respect to molecular determinants of virulence.
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Introduction
H5N1-HPAIV emerged in Egypt in 2006 [1] and was declared
endemic in 2008 [2]. Among the 181 human H5N1-HPAIV cases
reported worldwide between 2009 and 2011, 58.6% occurred in
this country alone [3]. Since Egypt became the new epicenter of
human H5N1-HPAIV infections, the increasing pandemic poten-
tial of H5N1-HPAIV is a major concern. H5N1-HPAIV causes
case fatality rates that are ten times higher than those seen during
the 1918 flu pandemic but its infectivity is much lower. An
infectivity of H5N1-HPAIV similar to seasonal flu would cause a
disastrous pandemic. This threat is compounded by variants of
H5N1-HPAIV that are less virulent and may even cause
asymptomatic human infections [4]. Moreover an increasing
infectivity of H5N1-HPAIV in humans paired with its silent spread
in humans could further accelerate its evolution and adaptation to
human-to-human transmission. Therefore there is an urgent need
to better understand viral determinants that facilitate human
infections by H5N1-HPAIV.
Entry of influenza virus into susceptible cells is mediated by the
viral hemagglutinin (HA) membrane glycoprotein binding to its
host cell receptor. Receptor binding selectivity of the HA protein
correlates to some extent with the host range of the virus. We have
recently used the informational spectrum method (ISM) to analyze
the interaction of HA with its receptor [5,6]. According to this
virtual spectroscopy method, the amino acid sequence of a protein
is transformed into a series of signals by assigning its electron-ion
interaction potential (EIIP) value to each amino acid. The
numerical series obtained is a (finite-length deterministic discrete)
signal containing information corresponding to the selective long-
range interaction between interacting proteins (interactions at
distances .100 A ˚; for a review see Ref. [7] and [8]). The signal
obtained is then decomposed into periodical functions by Fourier
transformation. The result is a series of frequencies each with its
own amplitude referred to as the Informational Spectrum (IS).
This technique allows the detection or definition of amplitude/
frequency pairs determining the specific long-range recognition
between interacting proteins [7,8]. The ISM approach has been
applied to a large range of proteins including anthrax protective
PLOS ONE | www.plosone.org 1 April 2013 | Volume 8 | Issue 4 | e61572antigen, p53, HIV-1 envelope glycoprotein gp120, lipoprotein
lipase, and others (for review see Ref. [7]). We have shown by ISM
that influenza HA1 protein encodes, despite its variability,
conserved information which characterizes recognition and
targeting of its receptor. This information is represented by
characteristic frequencies of IS of HA1 proteins. The comparison
of the IS of similar sets of viruses that differ by a characteristic
biological feature, e.g. their tropism or propensity to bind
preferentially to a human instead of an animal host receptor
permits to identify these characteristic frequencies. For instance,
North American H1N1 viruses from pigs had a high amplitude at
F(0.055) and a low amplitude at F(0.295), while the opposite was
observed for pandemic H1N1 virus. Interestingly, pig viruses
recovered from humans between 2005 and 2007 had a mixed
profile. Thus a characteristic shift from the frequency F(0.055),
characterizing the swine interacting profile, to the frequency
F(0.295) corresponding to the human tropism, was documented in
the evolution of swine H1N1 towards pandemic A(H1N1) [6].
In a similar study, we compared the IS of Egyptian H5N1-
HPAIV with a broad selection of 28 seasonal H1N1 viruses
isolated mainly from humans (n=19) but also from swine (n=5)
and avian (n=3) including also a mouse adapted laboratory strain.
The differences in amplitudes showed that the frequency F(0.076)
in the IS of HA1 corresponds to the preferred tropism of H5N1-
HPAIV and the frequency F(0.236) characterizes the tropism of
the seasonal H1N1 viruses [5]. The IS of most HA1 proteins from
Egyptian H5N1-HPAIV contained both of these frequency
components F(0.076) and F (0.236), but there was no IS similarity
between H5N1 and seasonal H3N2 or pandemic H1N1 2009
influenza viruses. The preference for either one frequency can be
described by the ratio between the amplitudes of the frequencies
F(0.076) and F(0.236) (A(0.076) and A(0.236)) in the IS of H5N1-
HPAIV HA1 [5]. We have speculated that a higher A(0.236)/
A(0.076) ratio would correspond to a higher selectivity for the
human receptor and a higher infectivity for humans [5].
Therefore, we extended our IS analysis of the evolution of
H5N1 in Egypt to include all strains between 2006 and 2011. In
order to further refine the IS analysis, we developed a phylogenetic
approach based on critical IS features that determine the host
tropism. We demonstrate that the IS-based phylogenetic analysis
of HA1 revealed that H5N1-HPAIV circulating in Egypt after
2009 acquired specific structural and informational properties
which may further increase their human-to-human transmission
and pandemic potential.
Materials and Methods
Sequences
All of the 526 published sequences of H5N1-HPAIV isolated in
Egypt between 2006 and 2011 were downloaded from NCBI [9]
and GISAID [10] databases (Dataset S1) and submitted to
phylogenetic analysis of HA1.
Informational Spectrum Method (ISM)
The ISM is based on the assumption that the protein-protein
interaction encompasses two basic steps: (i) recognition and
targeting between interacting proteins (long-range interactions at
distances .100 A ˚) and (ii) chemical binding (short range
interactions at distances ,5A ˚) (reviewed in Ref. [7] and [8]).
The long-range properties of biological molecules are determined
by EIIP representing the main energy term of valence electrons
[11]. The EIIP for organic molecules can be calculated by the
following simple equation derived from the ‘‘general model
pseudopotential’’ [12,13]:
W~
0:25Z sin(1:04pZ )
2p
ð1Þ
where Z* is the average quasivalence number (AQVN) determined
by
Z ~
X m
i~1
niZi
N
ð2Þ
where Zi is the valence number of the i-th atomic component, ni is
the number of atoms of the i-th component, m is the number of
atomic components in the molecule, and N is the total number of
atoms. The EIIP values calculated according to equations (1) and
(2) are expressed in Rydbergs (Ry) units.
The ISM assigns to each amino acid of the protein sequence its
EIIP value (Table 1). This numerical sequence, corresponding to
the protein sequence, is then subjected to a discrete Fourier
transformation which is defined as follows:
X(n)~
X N
m~1
x(m)e
{i2pnm
N, n~1,2,:::,N=2 ð3Þ
where x(m) is the m-th member of a given numerical series, N is
the total number of points in this series, and X(n) are discrete
Fourier transformation coefficients. These coefficients describe the
amplitude, phase and frequency of sinusoids which compose the
original signal. The absolute values of a complex discrete Fourier
transformation define the amplitude spectrum and the phase
spectrum. The complete information about the original sequence
Table 1. The electron-ion interaction potential (EIIP) used to
encode amino acids.
Amino acid EIIP [Ry]
Leu 0.0000
Ile 0.0000
Asn 0.0036
Gly 0.0050
Glu 0.0057
Val 0.0058
Pro 0.0198
His 0.0242
Lys 0.0371
Ala 0.0373
Tyr 0.0516
Trp 0.0548
Gln 0.0761
Met 0.0823
Ser 0.0829
Cys 0.0829
Thr 0.0941
Phe 0.0946
Arg 0.0959
Asp 0.1263
doi:10.1371/journal.pone.0061572.t001
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protein analysis, relevant information is presented in an energy
density spectrum [14], which is defined as follows:
S(n)~X(n)X (n)~ X(n) jj
2 , n~1,2,::,N=2 ð4Þ
In this way, sequences are analyzed as discrete signals. It is
assumed that their points are equidistant with the distance d=1.
The maximal frequency in a spectrum defined as above is F=1/
2 d=0.5. The frequency range is independent of the total number
of points in the sequence. The total number of points in a sequence
influences only the resolution of the spectrum. The resolution of
the N-point sequence is 1/N. The n-th point in the spectral
function corresponds to a frequency f(n)=nf=n/N. Thus, the
initial information defined by the sequence of amino acids can
now be presented in the form of the informational spectrum (IS),
representing series of frequencies and their amplitudes.
The IS frequencies correspond to the distribution of structural
motifs with defined physicochemical properties determining a
biological function of a protein [7,8]. When comparing proteins,
which share the same biological or biochemical function, the ISM
allows the detection of code/frequency pairs which are specific for
their common biological properties, or which correlate with their
specific interaction [7,8]. These common informational charac-
teristics of sequences are determined by cross-spectrum or
consensus informational spectrum (CIS). A CIS of M spectra is
obtained by the following equation:
C(j)~ P
M
i~1
S(i,j),j~1,2,:::,N=2 ð5Þ
where S(i,j) is the j-th element of the i-th power spectrum and C(j)
is the j-th element of CIS. Thus, CIS is the Fourier transform of
the correlation function for the spectrum. Thus, any spectral
component (frequency) not present in all compared informational
spectra is eliminated. Peak frequencies in CIS represent the
common information encoded in the primary structure of the
sequences analyzed. This information corresponds to the mutual
long-range interaction between the proteins of interest or their
interaction with the common interactor.
Phylogenetic Analysis
Phylogeny determines the evolutionary relationship within a
family of closely related sequences. Methods for constructing and
analyzing phylogenetic trees can be divided into three groups [15],
depending on the level of sequence similarity. The first group
includes maximum parsimony methods [16,17] used for quite
similar sequences. The strategy is to minimize the number of
evolutionary changes e.g. substitutions. The second group contains
distance methods [18] used for sequences that still share
recognizable sequence similarity. This approach is based on a
Figure 1. Comparison of informational spectra of seasonal H1N1 and Egyptian H5N1-HPAIV. (a) Cross-spectrum of HA1 of representative
seasonal H1N1 viruses (n=1576). (b) Cross-spectrum of all currently available Egyptian H5N1-HPAIV (n=526). (c) Cross-spectrum of Egyptian H5N1-
HPAIV isolated between 2006–2008 and (d) 2009–2011.
doi:10.1371/journal.pone.0061572.g001
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sequences. The distance scores are determined from the alignment
score [18] or uses various distance measure models [19,20]. In all
of these approaches evolutionary models are based on the multiple
sequence alignment (MSA). The matrix is then transformed into a
phylogenetic tree that represents genetic distances. The most
common algorithms are the neighbor-joining method (NJ) [21]
and the Unweighted Pair Group Method with Arithmetic Mean
(UPGMA) [22]. The third group of methods uses a probabilistic
approach to phylogeny. The trees are constructed by maximum
likelihood methods [23] or sampling methods [24].
A New Distance Measure for Phylogenetic Trees Based
on IS
The main weakness of phylogenetic analyses based on MSA, is
that sequence similarity does not necessarily imply similarity in
functions. For example, two protein sequences that differ by a
single mutation that is lethal for the biological function will
nevertheless phylogenetically group together, whereas two proteins
that differ in several mutations that do not affect biological
functions will be phylogenetically separated. In order to overcome
this obstacle and to improve functional sequence analysis, we
propose a new distance measure based on the IS method.
For comparison of two sets of sequences of proteins with two
different biological functions (here HA1 sequences from H5N1-
HPAIV infecting birds and seasonal H1N1 viruses infecting
humans) the first step is to identify the IS frequency components F1
and F2 that represent these two biological functions (here
F1=0.076 corresponding to the tropism of the H5N1-HPAIV,
and F2=0.236 corresponding to the tropism of the seasonal H1N1
virus). The characteristic frequencies F1 and F2 emerge as the
dominant peaks A(F1) and A(F2) in the consensus IS calculated for
each set of sequences as described above.
S1 and S2 are the IS spectra of the two sequences X1 and X2.
A1(F1) and A1(F2) are the amplitudes of the two characteristic
frequencies F1 and F2 of spectrum S1. Similarly, A2(F1) and A2(F2)
are the amplitudes of the sequences F1 and F2 of spectrum S2.
Then the distance between X1 and X2 is the absolute difference of
the amplitude ratios:
d(X1,X2)~
A1(F1)
A1(F2)
{
A2(F1)
A2(F2)
       
        ð6Þ
Let P be the set of values A(F1)/A(F2) for every sequence X,
where A(F1) and A(F2) are spectrum amplitudes of sequence S, at
the frequencies F1 and F2, respectively. Set P is a subset of the set
of real numbers R. Distance d is then the Euclidean distance on R,
and so it is a valid metric measure on P. It satisfies:
Figure 2. Comparison of informational spectra of H5N1-HPAIV from poultry and humans isolated 2006–2010. (a) A/chicken/Egypt/R1/
2006, (b) A/Egypt/2763-NAMRU3/2006, (c) A/chicken/Egypt/1029/2010, (d) A/Egypt/N04434/2010.
doi:10.1371/journal.pone.0061572.g002
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2. d(x,y)=0 u x=y, identity of indiscernibles
3. d(x,y)=d(y,x), symmetry
4. d(x,z) # d(x,y)+d(y,z), triangle inequality
It is also a valid additive evolutionary measure on P. It satisfies
additivity (four point condition): two of three sums d(x,y)+d(z,w),
d(x,z)+d(y,w), d(x,w)+d(y,z) are equal and larger than a third sum.
The distance matrix based on the distance d was used to generate
a phylogenetic tree using the following algorithm.
1. For each sequence calculate its spectrum
(a) Convert amino acid sequence into signal with EIIP values
(b) Decrease signal to zero mean
(c) Zero-padding to length of the longest signal, to set the
same resolution to all spectra
(d) Apply Fast Fourier Transformation to signal to generate
energy density spectrum
2. Calculate the cross-spectrum for each set of sequences to be
compared
3. Determine two characteristic frequencies F1 and F2 e.g. those
with the highest amplitude in these two cross-spectra
4. Calculate the distance matrix with the following distance
measure
d(X1,X2)~
A1(F1)
A1(F2)
{
A2(F1)
A2(F2)
       
       
5. Construct the tree using the NJ method.
Of note is that the conventional likelihood or bootstrap
validation are not applicable to our algorithm because the ISM
phylogenetic approach is not based on multiple sequence
alignments; it does not use a substitution model and the distance
measure is position specific. The NJ tree was generated using our
own service ISTREE [25], which is freely available on http://
istree.bioprotection.org/.
Results
Evolution of Egyptian H5N1 Strains by ISM-based
Phylogeny
The IS spectrum was calculated from 1576 publicly available
HA1 sequences of seasonal H1N1 viruses from different years and
geographic regions submitted to databases between May 2009 and
November 2012. No sequences of pandemic H1N1 2009 were
included in this set of viruses. The spectrum of a representative
example (shown in Figure 1A) and the cross-spectrum of this large
set of viruses showed a characteristic peak a the frequency
F(0.236). This corresponds to our earlier findings with a smaller set
of seasonal H1N1 viruses [5]. The cross-spectrum of all available
H5N1-HPAIV HA1 sequences (N=526) from Egypt showed a
characteristic peak at F(0.076) (Figure 1B). The cross-spectra of the
2006–2008 Egyptian H5N1-HPAIV showed only the peak at
F(0.076) (Figure 1C) whereas the 2009–2010 viruses showed a
highly dominant peak at F(0.236) (Figure 1D). Thus Egyptian
H5N1-HPAIV has also the characteristic peak of the seasonal
H1N1 viruses. Figure 2 shows the individual IS of Egyptian
H5N1-HPAIV obtained from poultry and humans in 2006 and
2010. The IS of the H5N1-HPAIV from 2006 (A/chicken/Egypt/
Figure 3. MSA-based and ISM-based phylogenetic analysis of H5N1-HPAIV isolated in Egypt. (a) The phylogenetic tree constructed using
the IS-based method. (b) Phylogenetic tree constructed by the neighbor-joining method.
doi:10.1371/journal.pone.0061572.g003
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(Figure 2B)) have the dominant peak at the frequency F(0.076)
typical for the H5N1-HPAIV using the avian receptor. The
H5N1-HPAIV isolated in 2010 (A/chicken/Egypt/1029/2010
(Figure 2C) and A/Egypt/N04434/2010 (Figure 2D)) have the
characteristic peak at the frequency F(0.236) typically found in the
seasonal H1N1 interacting only with the human receptor. This
suggests that H5N1-HPAIV circulating in Egypt in 2010 acquired
increasingly properties of human influenza possibly with an
increased propensity to react with the human receptor.
A phylogenetic tree was constructed using the A(0.236)/
A(0.076) ratio as a distance matrix of the H5N1-HPAIV HA1
sequences as described in the Materials and Methods (Figure 3A
and Figure S1 in high resolution). The tree structure revealed the
emergence of two or three separate groups, G1a, G1b and G2. All
G1 H5N1-HPAIV had an A(0.236)/A(0.076) ,1 (average
0.64660.224; Figure 4A) and all G2 viruses had an A(0.236)/
A(0.076) .1 (average 1.44560.311) (Figure 4A). The tree
structure also showed a dramatic shift from 100% G1 viruses in
2006 to 93.2% G2 viruses in 2011, with a marked increase from
6% to 54% in 2008/2009 (Figure 4B). After their strongest turnout
in 2008, the G1b viruses virtually disappeared in 2009/2010
(Figure 4B). Average values of the A(0.236)/A(0.076) ratio,
calculated for all Egyptian H5N1-HPAIV for each year, showed
a considerable increase of these values between 2006 and 2011
(Figure 4C). Furthermore 6.64% viruses with an A(0.236)/
A(0.076) .1 were isolated between 2006 and 2008, and 69.82%
of such viruses were isolated in the period 2009–2011. Thus, since
2006, more and more H5N1-HPAIV in Egypt acquired the
characteristic IS feature (e.g. the receptor interaction pattern) of
the seasonal H1N1. Figure 5 shows that there was a sudden
increase in the number of human cases confirmed by World
Health Organization (WHO) after 2008 [3]. Interestingly, in
2006–2008 there were 14 times more G1 viruses (n=225)
circulating than G2 viruses (n=16), but in humans G1 viruses
(n=25) were found only 4.1 times more often than G2 viruses
(n=6). In 2009–2011 G2 viruses (n=199) were only 2.3 times
more prevalent than G1 viruses (n=86), but they infected humans
9 times more often. Thus during both time periods G2 viruses
infected humans significantly more often than would be expected
from their overall prevalence (in humans and birds). Levels of
significance were p,0.02 in 2006/2008 and further increased in
2009/2011 (p,0.007; 1-sided Pearson Chi-Square test of propor-
tions). This is highly suggestive that viruses from the group G2
have an increased human tropism in comparison with viruses from
the group G1. This further suggests that H5N1-HPAIV from
group G2 have a higher affinity for humans and evolved towards
receptor usage similar to that of seasonal H1N1 viruses.
Homology analysis of 526 Egyptian H5N1-HPAIV HA1
sequences revealed four group-specific amino acids (Table 2,
Figure S4) that were consistently different between G1 and G2
viruses (the alignment of 526 Egyptian H5N1 HA1 sequences is
given in Dataset S2). All of G1 viruses had the amino acids D43,
S120, (S,L)129 and I151 whereas .94% of G2 viruses had N43,
(D,N)120, 129D and T151 (amino acid positions according to H5
numbering; Table S2). While Table S2 lists another 18 positions in
Figure 4. Distribution of A(0.236)/A(0.076) ratios by years for
Egyptian H5N1-HPAIV isolated during 2006–2011. (a) The
average values of A(0.236)/A(0.076) for G1 and G2 viruses. (b)
Distribution of G1 and G2 viruses by years. (c) The average values of
A(0.236)/A(0.076) by years.
doi:10.1371/journal.pone.0061572.g004
Figure 5. Correlation between A(0.236)/A(0.076) values of
Egyptian H5N1-HPAIV and human cases. The total average
A(0.236)/A(0.076) values and the number of human cases in Egypt
between 2006 and 2010 are shown.
doi:10.1371/journal.pone.0061572.g005
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were unique in their power to discriminate between G2 and G1
sequences. Both in poultry viruses and in human viruses the four
G2-typical amino acids steadily increased with time and were
mostly acquired after 2008 (Table 3).
The IS based phylogenetic tree shows that within the G2 group
even after acquisition of the changed amino acid pattern, the
A(0.236)/A(0.076) ratio continued to increase from 1.13 in 2009 to
an average value of 1,26 in 2011. The continued increase in this
ratio was the result of a number of additional mutations that
accumulated with time. Table 2 shows a selection of mutations
which increased the value of the A(0.236)/A(0.076) ratio and that
were found in at least 2 strains of Egyptian viruses analyzed.
Interestingly, most of these mutations were also found in G1
viruses, but G1 viruses have one, two or a maximum three of these
mutations from Table 2, which was not enough for the increase of
A(0.236)/A(0.076) above 1. In order to evaluate the cumulative
effect of these mutations, we compared the IS of the most recent
Egyptian H5N1-HPAIV HA1 sequence publicly available (A/
Egypt/N04434/2010; collected in March 2010) (Figure 6A) with
the IS of this HA1 with all mutations from the second line in
Table 2 (Figure 6B). The cumulative effect of these mutations
dramatically increased the A(0.236)/A(0.076) ratio from 1.79 for
the native protein (Figure 6A) to 5.11 for the mutated protein
(Figure 6B). This suggests that the acquisition of additional
mutations (that are already found in G1 viruses) by G2 viruses
bears further potential for human adaptation, whereas the G1
viruses do not have this potential. Therefore, the amino acid
substitutions given in Table 2 may represent valuable molecular
markers to further monitor the changing epidemiology of H5N1-
HPAIV infections towards human adaptation in Egypt.
Comparison of the ISM-based and the MSA-based
Phylogeny
Figure S2 and Figure 3B show the phylogenetic tree for
Egyptian H5N1-HPAIV viruses, based on the NJ and the
maximum likelihood method. Both trees have a very similar
structure confirmed by high bootstrap values. Similar to the IS-
based tree (Figures 3A and Figure S1), most of the G2 viruses
emerge from a single common branch in these conventional trees.
Therefore, we compared the sensitivity of the multiple sequences
alignment-based (MSA) and IS-based phylogenetic algorithms to
detect the above functionally important mutations. Figure 7A and
B present the MSA and IS-based trees of the HA1 sequences of all
311 G1 viruses. We introduced the four amino acids (43N, 120D,
129del, 151T) characteristic of G2 viruses into every second
sequence of the selected set. Figure 7C and D shows that in
contrast to the MSA-based tree which is not sensitive to the
mutations, the IS-based tree clearly segregated the mutated
sequences into the G2 cluster.
Furthermore, we identified 32 non-conserved positions in the
Egyptian sequence dataset (dataset S1, S2) by comparison with the
oldest Egyptian H5N1-HPAIV isolate in the dataset. These
positions were substituted by selected amino acids
(I=0.00000 Ry, P=0.01979 Ry, K=0.03718 Ry,
Y=0.05159 Ry, Q=0.07606 Ry, T=0.09408 Ry,
D=0.12630 Ry) with EIIP values, which are more or less evenly
distributed across the EIIP space (see Table 1). Each of the 32 non-
conserved amino acids was replaced by each of the above selected
amino acids. The impact of these monosubstitutions on the
A(0.236)/A(0.076) ratio was calculated for each position. Figure S3
shows the variation of the A(0.236)/A(0.076) ratio as a function of
the substitutions in the 32 positions. Table S1 shows the average
value of the change in A(0.236)/A(0.076) ratio for each of the
above amino acids when introduced into each of the non-
conserved positions. Both of these supplementary data show that
the positions considerably differ in their sensitivity to substitutions
by the different amino acids (Figure S3); and that the impact of
each amino acid greatly differs depending on the position (Table
S1).
We also generated the phylogenetic tree for each set of 32
sequences obtained by the monosubstitution by each of the
selected amino acids (I, P, K, Y, Q, T, D) in the 32 non-conserved
positions of HA. The results presented in Figures S5A – S5G show
that the tree structure of the IS-tree is strongly influenced by the
monosubstitutions. In contrast, Figures S5H – S5N show that the
MSA-based trees for the same substituted sequences is not sensitive
to the single amino acid substitutions.
Table 2. Residues that are specific for H5N1-HPAIV HA1 groups G1 and G2 (Figure 1A) and mutations that significantly increase
the A(0.236)/A(0.076) ratio.
Group G1 Group G2
Group-specific residues D43, S120, (S,L)129, I151 N43, (D,N)120, 129del, T151
Mutations that significantly increase
A(0.236)/A(0.076) ratio
P74S, H110R, A127T, F143Y, K153D, S188K, S223(N,I), S234P, G272S, N275S
Residue positions correspond the H5N1 numbering.
doi:10.1371/journal.pone.0061572.t002
Table 3. Number of G2 specific amino acid substitutions which are acquired before and after 2009.
Mutation Number of mutation (2006–2008) Number of mutation (2009–2011)
D43N 15 (7%) 200 (93%)
S120(N,D) 23 (12%) 196 (88%)
S129D 13 (6%) 191 (94%)
T151I 13 (6%) 207 (94%)
doi:10.1371/journal.pone.0061572.t003
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Here we developed an IS-based phylogenetic algorithm based
on the ratio of the amplitude at selected important frequencies as a
distance measure. The algorithm can be used to follow the
evolution of the interactive profile of viruses. We have used the
algorithm to analyze H5N1-HPAIV circulating in Egypt from
2006 to 2011 using the A(0.236)/A(0.076) ratio as a distance
measure. This analysis revealed that all HA1 sequences from
Egyptian H5N1-HPAIV which are available in the public
databases cluster in two groups G1 and G2 (Figure 3A and
Figure S1). Although the important G2 group was identified as a
separate cluster by both the IS-based and the conventional
phylogenetic tree, the conventional tree did not reveal particular
mutations that are associated with the evolution towards typical
features of seasonal (human) influenza. Our IS-based phylogenetic
approach is generic as it can utilize in the distance matrix any ratio
of amplitudes of two frequencies that are of interest with respect to
the interaction profile of a (viral) protein.
One of these groups (G2) shows a very dramatic propensity
towards high A(0.236)/A(0.076) ratios whereas only one subgroup
of G1 showed a weak propensity while the other did not. We
showed that the A(0.236)/A(0.076) ratio increases with time as a
result of more viruses having higher A(0.236)/A(0.076) ratios. The
high A(0.236)/A(0.076) ratios result mainly from four amino acid
mutations that are found in the G2 viruses but not in G1 viruses
(N84, 120(N,D), 129D and T151I). Among all amino acid
differences between G1 and G2 sequences these are unique in
their power to discriminate between G1 (.92%) and G2 (.94%)
viruses.
Recently Watanabe and coworkers reported that H5N1-
HPAIV with three of these mutations (S120N, 129D and I151T)
or even with the latter two alone, have an increased affinity for
a2,6-linked sialic acid (SA) [26] and an increased potential for
human H5N1-HPAIV infection. These authors further showed
that the 129S insertion and reverse mutation T151I decreased
a2,6 SA binding. In contrast, each of these amino acid
substitutions alone had no favorable effect on binding to the
human a2,6 SA. All viruses reported by Watanabe and coworkers
as BI and BII sublineages, characterized by the above mutations
(S120N, 129D and I151T) [26], belong to G2 viruses with the
preferred interacting profile similar to that of seasonal H1N1
viruses.
Since the peaks at F(0.236) and at F(0.076) are typical for
human seasonal H1N1 and for H5N1-HPAIV respectively [5], we
interpreted the increasing A(0.236)/A(0.076) ratio as a progressive
evolution of H5N1-HPAIV towards human tropism with a higher
selectivity for the human receptor and probably an increased risk
of human infections [5].
This is indeed supported by our observation that viruses with
high A(0.236/A(0.076) ratios were more likely to infect humans.
Already in 2006–2008 G2 viruses were significantly (p,0.02) more
often found in humans than was expected from their overall
prevalence. In 2009–2011 this became highly significant
(p,0.007) with 9 times more G2 viruses in humans compared to
only 2.3 fold relative overall prevalence. This is the more
interesting since there are no or only low human to human
transmissions and most viruses in humans dead-end. As a result
viruses with the double human/poultry tropism so far did not have
the opportunity to be selected for their human tropism in humans.
Several other lines of observations have subsequently confirmed
this:
(i) Kayali and coworkers identified a new sublineage of
H5N1-HPAIV within clade 2.2.1 named ‘‘Egypt-G’’ [27].
These viruses appeared in Egypt in 2009, and seemed to be
more adapted to human-to-human transmission. Their
analysis also revealed that these new viruses were less
virulent and may even cause asymptomatic infections and
that the silent spread of H5N1-HPAIV in humans
providing ample opportunities to further accelerate viral
evolution. According to these authors, most Egyptian
H5N1-HPAIV belonged to the sublineages Egypt E-F and
circulated exclusively in poultry. In contrast to Egypt-G
viruses, there was no evidence of human infections with the
latter viruses. All viruses of the sublineages Egypt-G
belonged to our group G2 and all Egypt E-F strains
belonged to G1 (Figure 3A).
(ii) The typical G2 mutations are rare in H5N1-HPAI viruses.
Analysis of all H5N1-HPAIV from Asia, Europe, America
and Africa from NCBI and GISAID databases, revealed
only 12 H5N1-HPAIV with the mutation 129D, and only 9
viruses with the combined mutations 129D and I151T.
The 129D deletion did not occur in H5N1-HPAIV
originally introduced into Egypt in 2006 [28,29]. Isolates
from non-human mammals likewise did not reveal the
129D. Interestingly, 129D viruses were found in the
majority of investigated human infections in Egypt in
Figure 6. Effect of mutations on informational spectra of the
Egyptian H5N1-HPAIV A/Egypt/N04434/2010. Effect of mutations
P74S, H110R, A127T, F143Y, K153D, S188K, S223(N,I), S234P, G272S,
N275S from Table 2) on IS of HA1 from human H5N1 virus A/Egypt/
N04434/2010. (a) IS of the unmutated HA1 protein, (b) IS of HA1 with
mutations.
doi:10.1371/journal.pone.0061572.g006
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important for human tropism of Egyptian H5N1-HPAIV are included to test the sensitivity of MSA- and ISM-based approach to mutations. (a) The MSA
tree and (b) the ISM tree for all 311 unmutated H5N1-HPAIV HA1 sequences belonging to G1 viruses; (c) the MSA tree of panel (a) in which each
second sequence was mutated and (d) the ISM tree which corresponds to the mutated and unmutated sequences presented in panel (c). H5N1-
HPAIV HA1 sequences selected for mutations D43N, S120D, S129D and I151T are in red.
doi:10.1371/journal.pone.0061572.g007
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seasonal H1N1 and H3N2 viruses [30].
(iii) Similarly, I141T is also seen in all human seasonal H1N1
and H3N2 viruses [30], while S120(N,D) is unique to
Egyptian H5N1-HPAIV.
(iv) The mutations recently reported by Kawaoka et al. [31]
(N224K, Q226L, T318I except N158D) which facilitated
transmission by droplets in ferrets increased the A(0.236)/
A(0.076) ratio when introduced for instance into the
Egyptian G1 virus selected by WHO as a new vaccine
candidate (A/Egypt/N03072/2010). N158 is present in
68% of all Egyptian H5N1-HPAIV both in G1 and G2
viruses, including very early strains isolated in 2006. This
mutation has no effect on the A(0.236)/A(0.076) ratio, but
its high prevalence further underlines the high pandemic
potential of Egyptian H5N1-HPAIV.
(v) There are numerous other studies which investigated
effects of mutations in H5N1-HPAIV HA1 on its binding
to a2,3 SA and a2,6 SA (reviewed in [32]). In Table 4 are
given mutations which increase binding of H5N1-HPAIV
HA1 to human receptor [28,29,33–38], but none of these
mutations were found in G1 nor in G2 viruses which
supposedly have an increased human tropism. The only
exception is the substitution S223N which facilitates a2,6
SA binding. This mutation also increases the A(0.236)/
A(0.076) ratio but is present in ,1% of Egyptian H5N1-
HPAIV (Table 2).
All of the above observations and experimental results provide
strong support that our phylogenetic algorithm based on a distance
matrix of the A(0.236)/A(0.076) ratio uniquely captures an
ongoing evolution of Egyptian H5N1-HPAIV towards human
tropism and probably a higher infectivity for humans. This
evolution is characterized by highly specific H5N1-HPAIV HA1
mutations, which we identified with a totally independent and
unrelated (computational) method based on a parameter that we
described already before the above publications, in particular
before the report of Watanabe which experimentally confirms the
human tropism of three of the four mutations that are most typical
for G2 viruses. In our 2009 publication Egyptian sequences only
from 2006 and 2007 were available including only 35 G2
sequences.
Recently, five H5N1-HPAIV HA1 sequences from Indonesia
2007 became available all of which exhibited the two mutations
129del and I151T and 3 strains have in addition N43 (GISAID),
characteristic for the G2 Egyptian viruses but none had the forth
substitution or any other Egyptian mutation that increases affinity
to the human receptor. Interestingly, Indonesian viruses do not
share the frequency F(0.236) with seasonal H1N1 or Egyptian G2
viruses. In the Indonesian H5N1-HPAIV the typical G2 mutations
do not increase the A(0.236)/A(0.076) ratio. This suggests that in
contrast to Egyptian H5N1-HPAI viruses the published Indone-
sian viruses did not evolve towards a human interacting profile but
no recent sequences are available.
Recently two neutralizing human antibodies were mapped to
aa125–129 [39–41], within the domain 99–133 which we
identified as essential for recognition and targeting of Egyptian
H5N1-HPAIV to human receptor [5] and which is highly
conserved in all H5N1-HPAIV clades with the exception of
Egyptian G2 viruses. In this H5N1-HPAIV HA1 region are
located two of four amino acid substitutions (N/D120 and S120D)
which are essential for increased human tropism of Egyptian
H5N1-HPAIV (Table 2). This strongly suggests that reported
human anti-H5N1-HPAIV antibodies will not be effective against
G2 viruses.
More importantly, however, in 2011 the WHO selected A/
Egypt/N03072/2010 as a new candidate vaccine virus [42]. This
virus does not contain N/D120 possibly compromising its
effectiveness against G2 viruses. As no new Egyptian viruses have
been made available on public data bases since 2010 the
importance of the G2 viruses may have been overlooked.
Of note is that G2 viruses are no longer confined to Egypt: 3 of
5 H5N1-HPAIV isolated in Israel in 2010 and 2011 have
mutations corresponding to Egyptian G2 viruses. Prior to 2010 all
H5N1-HPAIV in Israel were G1 viruses.
The mechanism underlying the emergence of H5N1-HPAIV in
Egypt with both a2,6 SA and a2,3 SA binding affinity is not clear.
One possible explanation is that this accelerated evolution of
H5N1 [43,44] is driven by the antigenic drift which is initiated by
the nationwide poultry vaccination campaign in Egypt with poorly
matching vaccines [45]. In conclusion, we analyzed here the
extensive evolution of HA1 from H5N1-HPAIV in Egypt towards
the human interacting profile using a novel phylogenetic approach
based on distance measures derived from the IS method. The
spread by asymptomatic infections in humans [2] as well as in wild
birds [46] of H5N1-HPAI viruses in Egypt that seem to
increasingly adapt to humans represents a major pandemic threat.
This underlines an urgent need to make sequences of H5N1-
HPAIV available for monitoring the evolution of molecular
determinants of virulence of H5N1-HPAI viruses.
Supporting Information
Figure S1 High resolution of the phylogenetic tree of
Egyptian H5N1-HPAIV based on ISM in Figure 3a.
(TIF)
Figure S2 High resolution of the phylogenetic tree of
Egyptian H5N1-HPAIV constructed by the maximum-
likelihood method.
(TIF)
Figure S3 Sensitivity of A(0.236)/A(0.076) ratio to
mutations in non-conserved positions of H5N1-HPAIV
HA1. A(0.236)/A(0.076) ratio as a function of single substitutions
with I, P, K, Y, Q, T, D in each of the 32 non-conserved positions
of H5N1 HA1 (GenBank: strain designation ABW37431).
(TIF)
Figure S4 Identification of non-conserved positions
over the whole sequence of HA1 from G1 and G2 viruses.
Table 4. Mutations that increase binding of H5N1-HPAIV HA1
to the human a2,6-linked sialic acid.
Mutations Reference
S223N, D183G, M E186G, Q192R, Q222L, G224S 30
N182K, Q192R 31
N182K, Q22L, G224S 32
N183G 33
D94N 34
(A,I,P,S,T)86V, (N,D)108S, (Q,H,I)122(L,N), A156(T,S), K112(E,R),
A163T
35
A86V, A156T 36
H125Q, V148A, N154D, Y157H, T159A, Y164C, W176R 37
doi:10.1371/journal.pone.0061572.t004
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(TIF)
Figure S5 Influence of position and type of mutation
HA1 from H5N1-HPAIV on MSA-based and ISM-based
phylogenetic tree. Phylogenetic tree for each set of 32
sequences obtained by the introduction of each selected amino
acid (I, P, K, Y, Q, T, D) in 32 non-conserved positions of HA. (A)
- (G), phylogenetic trees based on ISM, (H) – (N) phylogenetic
trees constructed by the neighbor-joining method. The wild-type
sequence (ABW37431/A/chicken/Egypt/R1/2006) is highlighted
in each tree. All other sequences have a single substitution by one
of the above amino-acids (panel A,H: amino acid substitution by I;
panel B,I: substitution by P etc. …) in the different non-conserved
positions. The substitution is given as part of the strain name.
(TIF)
Table S1 Average and standard deviation of the
A(0.236)/A(0.076) values. A(0.236)/A(0.076) ratios correspond
to single amino-acid substitution in each of the 32 non-conserved
positions by I, P, K, Y, Q, T, D. Each value corresponds to a tree
in Figure S5, panel A-G.
(DOC)
Table S2 Distribution of group-specific amino-acids
between G1 and G2 viruses.
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Dataset S1 FASTA-formatted file of the 526 sequences of
Egyptian H5N1-HPAIV. Viruses from 2006 to 2011 published
on NCBI and GISAID are included.
(TXT)
Dataset S2 Alignment of HA1 sequences of the 526
Egyptian H5N1-HPAIV included in this study.
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